BDBM135796 US8853242, 211
SMILES: [#7]\[#6](-[#7])=[#7]\[#6](=O)-c1ccc2c(Cl)cnc(-c3ccc(F)cc3F)c2c1
InChI Key: InChIKey=RTCPHQATTMCCCB-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 5A (Homo sapiens (Human)) | BDBM135796 (US8853242, 211) | KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 2.30 | -11.8 | n/a | n/a | n/a | n/a | n/a | 7.5 | 25 |
Astellas Pharma Inc. US Patent | Assay Description A solution of the compound to be tested and 100 μM 5-CT (5-carboxamidetriptamine) in DMSO was added to a 96-well plate at 2 μl/well, suspen... | US Patent US8853242 (2014) BindingDB Entry DOI: 10.7270/Q2NP2346 | |||||||||||
More data for this Ligand-Target Pair |